Skip to content

Adaptive Support Ventilation in Acute Respiratory Distress Syndrome

Adaptive Support Ventilation in Acute Respiratory Distress Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03715751
Acronym
ARDS
Enrollment
20
Registered
2018-10-23
Start date
2018-02-14
Completion date
2021-01-31
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Keywords

Adaptive Support Ventilation, ARDS, Esophageal Pressure, Mechanical Ventilation, Transpulmonary Pressure

Brief summary

The purpose of this protocol is to compare standard of care lung protective ventilation settings with an automated ventilator setting, called Adaptive Support Ventilation (ASV), in patients with acute respiratory distress syndrome (ARDS). This study will compare measurements (i.e. tidal volumes, driving pressure, respiratory rate (RR), compliance, peak airway pressures, plateau pressures, PEEP) with each ventilator technique, and will measure esophageal pressures to compare transpulmonary and respiratory system mechanics.

Detailed description

This study will compare two different modes of mechanical ventilation: standard lung protective controlled mandatory ventilation and Adaptive Support Ventilation. The investigators will enroll adult patients with ARDS who are mechanically ventilated and admitted to intensive care units, capturing a population with respiratory failure and significant critical illness. Patient mechanics during each ventilation strategy will be compared before and after crossover. After obtaining informed consent, the investigators will place an esophageal balloon which will be used for simultaneous measurements of airway pressures (Pao) and esophageal pressures (Pes), to estimate transpulmonary pressures (PL = Pao - Pes), while also measuring Flow and Volume. Use of esophageal balloon catheters is common practice in the ICUs, and standard of care at Beth Israel Deaconess Medical Center is to use these balloons in patients with ARDS. Both the respiratory therapy and physician staff are very comfortable with placement and use. The esophageal balloon will be left in place until extubation. If the balloon is dislodged or removed for clinical purposes, it will not be replaced solely for research purposes unless it occurs on the first day of study measurements. Patients will then be randomized to be switched to ASV immediately or to be maintained on their current lung protective ventilation settings.

Interventions

OTHERASV

Adaptive Support Ventilation

Targeted tidal volume of 6cc/Kg, Positive Inspiratory Pressure titrated per ARDS guidelines.

Sponsors

Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients ≥ 18 years of age 2. Receiving mechanical ventilation in an intensive care unit 3. ARDS, as defined by the Berlin definition: 1. Hypoxemic respiratory failure with PaO2 / FiO2 ratio \< 300 mmHg 2. Bilateral alveolar/interstitial infiltrates on chest x-ray, with opacities not present for more than 7 days 3. Respiratory failure not fully explained by cardiac failure or fluid overload 4. Intubation on mechanical ventilation and receiving PEEP ≥ 5 cm H2O 4. Receiving mechanical ventilation from a Hamilton ventilator, on a controlled mode of ventilation.

Exclusion criteria

1. Clinical team refusal 2. Esophageal injury or contraindication precluding placement of the esophageal balloon

Design outcomes

Primary

MeasureTime frameDescription
Tidal VolumeDay 1Lung tidal volume in both ventilation modes (mL)

Secondary

MeasureTime frameDescription
Respiratory rate (BPM)Day 1Respiratory Rate in both ventilation modes
Oxygenation (SpO2%)Day 1Oxygenation (SpO2%) in both ventilation modes
CO2 clearanceDay 1CO2 clearance in both ventilation modes
Blood Gas pHDay 1Blood Gas pH (units) in both ventilation modes
Blood Gas Partial Pressure of OxygenDay 1Partial pressure of oxygen (PaO2) (mm Hg) in both ventilation modes
Blood Gas Partial Pressure of Carbon Dioxide (PaCO2) (mm Hg)Day 1Partial Pressure of Carbon Dioxide (PaCO2) (mm Hg) in both ventilation modes
Composite measure (lung protectiveness) - Asynchrony indexDay 1Asynchrony index
Driving Pressure (cmH20)Day 1Driving pressure in both ventilation modes
Composite measure (lung protectiveness) - Time with tidal volumes under 6cc/kgDay 1Time spent with tidal volumes less than or equal to 6cc/kg
Composite measure (lung protectiveness) - Driving pressures less than 15Day 1Time spent at or under Driving pressures less than 15
Composite measure (lung protectiveness) - Plateau Pressure <30Day 1Time spent at or under Plateau Pressure \<30
Composite measure (lung protectiveness) - Oxygen saturation by pulse Oximetry (SpO2) >88%Day 1Time spent at or under Oxygen saturation by pulse Oximetry (SpO2) \>88%
Time to extubation30 DaysTime to liberation from mechanical ventilation (days)
ICU length of stay90 DaysTime to ICU discharge (days)
Composite measure (lung protectiveness) - Number of AdjustmentsDay 1Number of Adjustments

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026